N/A
N=51
The Effects of Broccoli Sprout Extract on Obstructive Lung Disease
Asthma · COPD
Bottom Line
View on ClinicalTrials.gov: NCT00994604 ↗Enrolled (actual)
51
Serious AEs
0.0%
Results posted
Jan 2017
Primary outcome: Primary: The Primary Outcome is the Change in Bronchodilation and Bronchoprotection After Broccoli Sprout Extract — 10.3; 26.7 index
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- broccoli sprout extract (Drug)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Johns Hopkins University
- Primary completion
- Aug 2015
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY The Primary Outcome is the Change in Bronchodilation and Bronchoprotection After Broccoli Sprout Extract |
10.3; 26.7 | — |
| SECONDARY Changes in Airway Size by Computed Tomography |
30.9; 32 | — |
Summary
The purpose of this study is to examine whether broccoli sprout extract can effect lung function measurements in individuals with asthma and COPD.
Eligibility Criteria
Inclusion Criteria
- asthma
- COPD
Exclusion Criteria
- currently on chronic oral steroid medications
- current respiratory symptoms
- pregnant
- FEV1 less than 40% predicted at baseline
- extreme degrees of bronchial hyperreactivity
- recent respiratory infection (<3 weeks)
- unstable symptoms in the prior month
- a history of intubation for respiratory symptoms within the past year
- any history of cardiac disease.
Data sourced from ClinicalTrials.gov (NCT00994604). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.